Recently, it has been popularly labeled "natures Ozempic," referencing its claimed similarities to the pharmaceutical agent Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist approved for managing type 2 diabetes mellitus and facilitating weight loss
"Mitochondria as a Target for Peptide Regulation of Aging." Advances in Gerontology, 2019
The 35% number and why you won't see it yet The savings story spreading online runs something like: "Generics are 45 to 90% cheaper than brand drugs
Acknowledgements (02:07:25) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices